This has already materialized and there is no trace back on its balance sheet. So it doesn't impact its current market valuation too much.
Plus two things to consider: Financials are at their lower bottom line, and the ER is coming in less than 2 weeks (BAC ER is July 16). Not a smart move if short at here.